The changing incidence of rheumatoid arthritis over time in north-west Greece: data from a referral centre

Venetsanopoulou, Aliki I.; Alamanos, Yannis; Skalkou, Anastasia; Aa, Drosos

doi:10.1080/03009742.2022.2058178

Cited by 10 publications

(3 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The global prevalence of RA is reported at the level of 460 cases per 100,000 population, which varies in different regions depending on the definition of the disease, geographic characteristics, and study design [2]. Several studies have reported an increase in the incidence and/or prevalence of RA in some countries in recent years [3][4][5].…”

Section: Introductionmentioning

confidence: 99%

How Different Is The Status Of Depression And Anxiety In Patients With Rheumatoid Arthritis Receiving Methotrexate With Sulfasalazine Or Hydroxychloroquine?

Babaei,

Dorparvar,

Ghahari

et al. 2023

Russ Open Med J

View full text Add to dashboard Cite

Background — Depression and anxiety are among the most common clinical manifestations in patients with rheumatoid arthritis (RA). Sulfasalazine and hydroxychloroquine are important medications used to treat these patients. Objective — The goal of this study was to compare the occurrence of depression and anxiety in RA patients taking sulfasalazine or hydroxychloroquine for at least six months. Methods — This study included 300 patients with RA referred to inpatient or outpatient departments of a public hospital in northern Iran who were treated with two combination regimens of methotrexate and sulfasalazine or methotrexate and hydroxychloroquine. Participants were assessed on the standard Hospital Anxiety and Depression Scale (HADS) for symptoms of depression and anxiety. Results — The mean HADS depression subscale score was 6.77±3.98 in the hydroxychloroquine group and 3.50±3.53 in the sulfasalazine group (p<0.001). The mean HADS anxiety subscale score was 7.66±4.43 in the hydroxychloroquine group and 5.34±4.35 in the sulfasalazine group (p<0.001). Multiple linear regression analysis revealed a significant difference in the incidence of depression and anxiety between the two treatment groups. Conclusion — A higher prevalence of depression and anxiety was observed in RA patients treated with methotrexate and hydroxychloroquine versus those treated with methotrexate with sulfasalazine.

show abstract

Section: Introductionmentioning

confidence: 99%

How Different Is The Status Of Depression And Anxiety In Patients With Rheumatoid Arthritis Receiving Methotrexate With Sulfasalazine Or Hydroxychloroquine?

Babaei,

Dorparvar,

Ghahari

et al. 2023

Russ Open Med J

View full text Add to dashboard Cite

show abstract

“…Whereas studies from other Western countries have indicated a decreasing or stable trend for seropositive RA and an increasing or stable trend for seronegative RA using either RF or ACPA to define seropositivity (18,42,110). Study II revealed that the peak in IR of overall RA in 2010 was driven by temporal trends in seropositive RA.…”

Section: Incidence Of Seropositive and Seronegative Rheumatoid Arthritismentioning

confidence: 89%

“…IRs in 2018 varied from 17 to 19 and 8 to 9 per 100 000 PY for seropositive and seronegative RA, respectively, depending on the outcome definition of seropositivity applied. Both estimates were lower than reported in other Western countries except in Greece, though heterogenicity between the studies existed (18,106,109,110). Besides the heterogeneity in methodological approaches, these differences might be due to the suspected underestimation of IRs in 2017 and 2018 in Study II caused by delayed and suboptimal registration in the DNPR after the introduction of a new healthcare information technology system in two of the Danish regions (Appendix B) (1).…”

Section: Incidence Of Seropositive and Seronegative Rheumatoid Arthritismentioning

confidence: 95%

The Risk of Rheumatoid Arthritis: Incidence, Prevalence, and Mortality

Soussi

View full text Add to dashboard Cite

General rightsCopyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.-Users may download and print one copy of any publication from the public portal for the purpose of private study or research. -You may not further distribute the material or use it for any profit-making activity or commercial gain -You may freely distribute the URL identifying the publication in the public portal -

show abstract